JP6388941B2 - ビタミンｄ代謝物を測定するための２５−ｏｈビタミンｄ誘導体 - Google Patents

ビタミンｄ代謝物を測定するための２５−ｏｈビタミンｄ誘導体 Download PDF

Info

Publication number
JP6388941B2
JP6388941B2 JP2016532339A JP2016532339A JP6388941B2 JP 6388941 B2 JP6388941 B2 JP 6388941B2 JP 2016532339 A JP2016532339 A JP 2016532339A JP 2016532339 A JP2016532339 A JP 2016532339A JP 6388941 B2 JP6388941 B2 JP 6388941B2
Authority
JP
Japan
Prior art keywords
vitamin
group
compound
formula
tracer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016532339A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016532695A5 (enExample
JP2016532695A (ja
Inventor
ソスキッチ ヴキッチ
ソスキッチ ヴキッチ
ポッペ ローベアト
ポッペ ローベアト
Original Assignee
オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング
オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング, オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2016532695A publication Critical patent/JP2016532695A/ja
Publication of JP2016532695A5 publication Critical patent/JP2016532695A5/ja
Application granted granted Critical
Publication of JP6388941B2 publication Critical patent/JP6388941B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP2016532339A 2013-08-07 2014-08-01 ビタミンｄ代謝物を測定するための２５−ｏｈビタミンｄ誘導体 Active JP6388941B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102013215580.8 2013-08-07
DE102013215580.8A DE102013215580A1 (de) 2013-08-07 2013-08-07 25-OH Vitamin D Derivate zur Bestimmung von Vitamin D Metaboliten
PCT/EP2014/066620 WO2015018757A1 (de) 2013-08-07 2014-08-01 25-oh vitamin d derivate zur bestimmung von vitamin d metaboliten

Publications (3)

Publication Number Publication Date
JP2016532695A JP2016532695A (ja) 2016-10-20
JP2016532695A5 JP2016532695A5 (enExample) 2017-06-15
JP6388941B2 true JP6388941B2 (ja) 2018-09-12

Family

ID=51298740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016532339A Active JP6388941B2 (ja) 2013-08-07 2014-08-01 ビタミンｄ代謝物を測定するための２５−ｏｈビタミンｄ誘導体

Country Status (10)

Country Link
US (2) US10222388B2 (enExample)
EP (1) EP3030243B1 (enExample)
JP (1) JP6388941B2 (enExample)
CN (1) CN105636595B (enExample)
AU (1) AU2014304585A1 (enExample)
DE (1) DE102013215580A1 (enExample)
IL (1) IL243856A0 (enExample)
MX (1) MX2016001519A (enExample)
RU (1) RU2016108014A (enExample)
WO (1) WO2015018757A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016065042A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Therapeutic vitamin d conjugates
WO2016065052A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Insulin vitamin d conjugates
US20160161473A1 (en) 2014-12-08 2016-06-09 Calbiotech, Inc. Biotin conjugates of analytes containing amino, hydroxyl, or thiol functional groups for use in immunodiagnostic assays
CN111518008B (zh) * 2019-02-01 2023-02-28 科美博阳诊断技术(上海)有限公司 用于测定维生素d的含量或存在的化合物、产品和方法
CN115850141B (zh) * 2019-02-01 2024-09-20 科美博阳诊断技术(上海)有限公司 一种中间体化合物及其制备方法和应用
CN112485418B (zh) * 2020-10-26 2023-04-11 北京利德曼生化股份有限公司 一种用于人体维生素b12含量检测的释放剂及其应用
JP2025534350A (ja) 2022-09-30 2025-10-15 エクステンド バイオサイエンシズ インコーポレーテッド 長時間作用型副甲状腺ホルモン
CN119192387B (zh) * 2023-06-25 2025-11-18 东莞市朋志生物科技有限公司 抗25-oh-vd及其抗体复合物的抗体、检测25-oh-vd的试剂和试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119647A (en) * 1977-04-11 1978-10-10 Hoffmann-La Roche Inc. 25-Hydroxycholecalciferol-23,24-3 H and process for the preparation thereof
JPH075542B2 (ja) 1988-09-14 1995-01-25 呉羽化学工業株式会社 ビタミンｄ▲下３▼誘導体及びその製造方法
CH681891A5 (enExample) 1992-10-09 1993-06-15 Marigen Sa
US5422127A (en) * 1992-12-21 1995-06-06 Bristol-Myers Squibb Company Nutritional compositions containing vitamin D esters
US5478816A (en) * 1993-07-02 1995-12-26 Bristol-Myers Squibb Company Liquid vitamin formulations containing vitamin D esters
WO1997024127A1 (en) * 1995-12-29 1997-07-10 A And D Assay, Incorporated Labeled vitamin d compounds and the use thereof
GB9623569D0 (en) 1996-11-13 1997-01-08 Immunodiagnostic Systems Ltd Vitamin D immumoassay systems
US6017908A (en) 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
DE19981132D2 (de) 1998-06-25 2001-10-18 Immundiagnostik Ges Fuer Produ Funktionelle Vitamin-D-Derivate und Verfahren zur Bestimmung von 25-Hydroxy- und 1alpha,25-Dihydroxy-Vitamin-D
CA2624124A1 (en) 2005-09-29 2007-04-12 F. Hoffmann-La Roche Ag Antibodies against 25-hydroxyvitamin d
JP5572318B2 (ja) * 2005-12-30 2014-08-13 ルバンス セラピュティックス インク． 局所投与用アルギニンヘテロマー
KR20090025239A (ko) 2006-05-16 2009-03-10 프리스케일 세미컨덕터, 인크. 패드 및 입출력(ｉ／ｏ) 셀을 갖는 집적 회로
ES2336382T3 (es) 2006-06-06 2010-04-12 F. Hoffmann-La Roche Ag Medicion mejorada de la vitamina d.
JP2010053118A (ja) 2008-07-28 2010-03-11 Fujifilm Corp ビオチン化チロキシン
CN102628872A (zh) * 2012-03-31 2012-08-08 广州菲康生物技术有限公司 25羟基维生素d检测试剂盒及其制备方法
DE102013205055A1 (de) 2013-03-21 2014-09-25 Orgentec Diagnostika Gmbh Verfahren und Reagenz zur Bestimmung von Vitamin D Metaboliten

Also Published As

Publication number Publication date
EP3030243B1 (de) 2017-07-26
IL243856A0 (en) 2016-04-21
AU2014304585A1 (en) 2016-02-18
EP3030243A1 (de) 2016-06-15
CN105636595A (zh) 2016-06-01
WO2015018757A1 (de) 2015-02-12
CN105636595B (zh) 2019-08-27
MX2016001519A (es) 2016-06-23
RU2016108014A (ru) 2017-09-08
US20160195556A1 (en) 2016-07-07
US10222388B2 (en) 2019-03-05
DE102013215580A1 (de) 2015-02-12
JP2016532695A (ja) 2016-10-20
US11199553B2 (en) 2021-12-14
US20190101548A1 (en) 2019-04-04
US20170115313A9 (en) 2017-04-27

Similar Documents

Publication Publication Date Title
JP6388941B2 (ja) ビタミンｄ代謝物を測定するための２５−ｏｈビタミンｄ誘導体
JP6750066B2 (ja) ビタミンｄ結合タンパク質からビタミンｄを解離するための溶液、その関連検出法及び使用
JP4130958B2 (ja) ビタミンｄアッセイ
JP4187929B2 (ja) 機能性ビタミンＤ誘導体の製造方法および２５−ヒドロキシおよび１α，２５−ジヒドロキシビタミンＤ代謝物の検出用試薬セット
US10472400B2 (en) Cardiac troponin I ultra-sensitive detection reagent kit, and ultra-sensitive detection method therefor
US20040132104A1 (en) Vitamin D assay
US8133694B2 (en) Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D
KR20160047422A (ko) 비타민 ｄ를 검출하기 위한 조성물 및 방법
JP5202527B2 (ja) 抗原タンパク質コンジュゲートおよびその製造方法
US9863963B2 (en) Method and reagent for determining vitamin D metabolites
JP4068137B2 (ja) ビオチニル化した化学発光性標識、結合体、測定法及び測定法キット
JP2017142241A (ja) 検体中のステロイドホルモンの測定方法
CN103649069A (zh) 闪光和辉光1，2-二氧杂环丁烷类
JP6494599B2 (ja) 分解可能なカチオン界面活性剤および化学発光を増強するためのその利用
WO2009056782A1 (en) Luminescence
CN111175495A (zh) 一种测定胃泌素17含量的试剂盒及其使用方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170425

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170425

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180618

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180717

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180815

R150 Certificate of patent or registration of utility model

Ref document number: 6388941

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250